30 December 2022 | News
The changing lifestyles of the affluent middle-class lead to the disease burden shifting from communicable diseases to non-communicable diseases
Pathomics Health has signed a Memorandum of Understanding (MoU) with MAHSA Health to set up a Joint Centre for Research and Diagnostics Services for Precision Wellness and Clinical Research at MAHSA Avenue.
The collaboration focuses on health and wellness screening with MAHSA Health to optimise the wellbeing of individuals in Malaysia. Clinical research will also be part of the partnership to further support clinicians in their clinical care for patients across the MAHSA Health's network of hospitals and clinics.
Combined expertise from both parties will make a significant impact on the health and wellness of MAHSA Health's patients and cement the Joint Centre's position as a Centre of Excellence for genomics to support MAHSA Health in its advancement of healthcare services, research, and innovation in ASEAN.
With its latest collaboration with MAHSA, Pathomics Health will provide the Malaysian public and medical tourists visiting Malaysia access to its advance health screening tools beyond genomics profiling tests services offered across MAHSA health network of primary care clinics and hospital.
"The genomics profiling test is a start for an individual to better understand one's health risks profile for Cardiovascular, Cancer and Diabetes. With the diverse health screening tests options, it also acts as a compass for family physicians to personalise health screening tests to better meet their patients' unique health profile", said Michael Tan, Director of Pathomics Health.